GlucoTrack (GCTK) Competitors $5.37 -0.35 (-6.12%) Closing price 04:00 PM EasternExtended Trading$5.57 +0.20 (+3.74%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GCTK vs. QTI, LYRA, TNON, INBS, LUCY, ICU, HSCS, CODX, SINT, and SSKNShould you be buying GlucoTrack stock or one of its competitors? The main competitors of GlucoTrack include QT Imaging (QTI), Lyra Therapeutics (LYRA), Tenon Medical (TNON), Intelligent Bio Solutions (INBS), Innovative Eyewear (LUCY), SeaStar Medical (ICU), HeartSciences (HSCS), Co-Diagnostics (CODX), Sintx Technologies (SINT), and Strata Skin Sciences (SSKN). These companies are all part of the "medical equipment" industry. GlucoTrack vs. Its Competitors QT Imaging Lyra Therapeutics Tenon Medical Intelligent Bio Solutions Innovative Eyewear SeaStar Medical HeartSciences Co-Diagnostics Sintx Technologies Strata Skin Sciences GlucoTrack (NASDAQ:GCTK) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, media sentiment, institutional ownership, risk, earnings and dividends. Does the media refer more to GCTK or QTI? In the previous week, GlucoTrack had 4 more articles in the media than QT Imaging. MarketBeat recorded 4 mentions for GlucoTrack and 0 mentions for QT Imaging. GlucoTrack's average media sentiment score of 0.28 beat QT Imaging's score of 0.00 indicating that GlucoTrack is being referred to more favorably in the media. Company Overall Sentiment GlucoTrack Neutral QT Imaging Neutral Which has more risk & volatility, GCTK or QTI? GlucoTrack has a beta of -0.19, suggesting that its share price is 119% less volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.2, suggesting that its share price is 120% less volatile than the S&P 500. Is GCTK or QTI more profitable? Company Net Margins Return on Equity Return on Assets GlucoTrackN/A N/A -352.05% QT Imaging N/A N/A -65.94% Which has stronger valuation and earnings, GCTK or QTI? QT Imaging has higher revenue and earnings than GlucoTrack. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlucoTrackN/AN/A-$22.60M-$56.60-0.09QT Imaging$4.00M14.39-$4.03MN/AN/A Do insiders and institutionals hold more shares of GCTK or QTI? 10.9% of GlucoTrack shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 12.9% of GlucoTrack shares are owned by insiders. Comparatively, 75.4% of QT Imaging shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryQT Imaging beats GlucoTrack on 5 of the 8 factors compared between the two stocks. Get GlucoTrack News Delivered to You Automatically Sign up to receive the latest news and ratings for GCTK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GCTK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GCTK vs. The Competition Export to ExcelMetricGlucoTrackMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.73M$10.67B$5.73B$9.80BDividend YieldN/A1.90%4.54%4.08%P/E Ratio-0.0920.1830.7425.12Price / SalesN/A28.04441.05108.85Price / CashN/A24.7437.3459.16Price / Book0.373.388.886.24Net Income-$22.60M$209.94M$3.26B$265.56M7 Day Performance-6.77%1.01%1.73%0.90%1 Month Performance-7.89%9.97%3.54%1.88%1 Year Performance-99.81%-11.39%28.63%20.09% GlucoTrack Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GCTKGlucoTrack0.39 of 5 stars$5.37-6.1%N/A-99.8%$2.73MN/A-0.095Earnings ReportQTIQT ImagingN/A$1.90+2.7%N/A+300.4%$10.72M$4.00M0.00N/AGap UpLYRALyra Therapeutics3.1392 of 5 stars$6.75+1.2%$100.00+1,381.5%-51.1%$10.66M$1.53M-0.1150Earnings ReportAnalyst RevisionTNONTenon Medical2.0419 of 5 stars$1.47+6.5%$4.67+217.5%+225.6%$10.47M$3.28M-0.058Earnings ReportShort Interest ↑INBSIntelligent Bio Solutions0.7235 of 5 stars$1.47+2.1%N/A+40.2%$9.95M$3.11M0.0010News CoverageEarnings ReportAnalyst UpgradeLUCYInnovative Eyewear0.8427 of 5 stars$1.97-2.0%N/A-47.5%$9.19M$1.64M-0.499Earnings ReportShort Interest ↓ICUSeaStar Medical0.2477 of 5 stars$0.73-6.2%N/A-87.3%$8.72M$140K-0.212Earnings ReportHSCSHeartSciences3.3473 of 5 stars$3.39-9.1%$13.00+283.5%+4.7%$8.49MN/A-0.3610Gap UpCODXCo-Diagnostics4.428 of 5 stars$0.25+0.5%$5.50+2,067.9%-76.6%$8.48M$3.91M-0.22100News CoverageEarnings ReportShort Interest ↓Gap DownSINTSintx Technologies2.4396 of 5 stars$2.99+3.5%$28.00+836.5%-28.5%$7.96M$2.89M-0.0640Earnings ReportShort Interest ↓SSKNStrata Skin Sciences2.3425 of 5 stars$1.81-4.7%$6.00+231.5%-29.5%$7.92M$33.56M-0.80120Earnings Report Related Companies and Tools Related Companies QTI Alternatives LYRA Alternatives TNON Alternatives INBS Alternatives LUCY Alternatives ICU Alternatives HSCS Alternatives CODX Alternatives SINT Alternatives SSKN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GCTK) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlucoTrack, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlucoTrack With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access